Angioplasty, Transluminal, Percutaneous Coronary Clinical Trial
Official title:
A Multinational, Randomized, Double-Blind, Double-Dummy, Exploratory, Parallel Group, Dose-Ranging Phase II Study to Evaluate Pharmacodynamics, Safety and Tolerability, and Pharmacokinetics of Several Intravenous Regimens of Factor Xa Inhibitor Otamixaban (XRP0673), in Comparison to Intravenous Unfractionated Heparin, in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention
The objective of this dose-ranging study is to determine the effects of several intravenous (IV) regimens of otamixaban on pharmacodynamic markers (including markers of thrombosis and coagulation markers), safety/tolerability, clinical efficacy and pharmacokinetics.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01179126 -
Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease
|
Phase 3 | |
| Completed |
NCT01174433 -
Safety Study to Assess the FEasibility of Use of the TRYTON Bifurcation Coronary Stent System (SAFE-TRY)
|
Phase 1/Phase 2 | |
| Completed |
NCT01004575 -
Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT00500279 -
Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial
|
Phase 4 | |
| Completed |
NCT00345501 -
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
|
Phase 2/Phase 3 | |
| Completed |
NCT00269893 -
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty
|
Phase 3 | |
| Completed |
NCT00398463 -
Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance
|
Phase 4 | |
| Completed |
NCT00356044 -
Arterial Access for Coronary Intervention in Myocardial Infarction
|
Phase 4 | |
| Completed |
NCT00269906 -
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty
|
Phase 3 | |
| Not yet recruiting |
NCT03047772 -
Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
|
Phase 2 | |
| Completed |
NCT02039739 -
Orsiro™ Drug Eluting Stent in Routine Clinical Practice
|
||
| Completed |
NCT01241903 -
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
|
Phase 1 | |
| Completed |
NCT00574691 -
ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU
|
Phase 1 | |
| Active, not recruiting |
NCT02200783 -
Randomized Comparison of Radiological Exposure With TRIPTable® in Patients With Acute Coronary Syndromes
|
N/A | |
| Terminated |
NCT02039713 -
DESyne in Routine Clinical Practice
|
||
| Not yet recruiting |
NCT00938522 -
Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention
|
Phase 4 | |
| Recruiting |
NCT00637104 -
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
|
Phase 2/Phase 3 | |
| Completed |
NCT00533156 -
Plug Arterial Closure System (PACS, 7F)
|
Phase 2 | |
| Completed |
NCT00610870 -
Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention
|
N/A | |
| Completed |
NCT00390585 -
Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)
|
Phase 4 |